Associate Director of Regulatory Affairs, CMC

This position is listed on behalf of a partner company, who manages all applications and next steps. Our partner is looking for a Associate Director of Regulatory Affairs, CMC based in United States. This senior regulatory role will support late-stage development, commercial launch, and lifecycle management for an innovative cell therapy pipeline. You will provide hands-on CMC regulatory expertise across global submissions, health authority interactions, and post-approval activities. The position offers substantial ownership of complex regulatory content, including BLA, MAA, IND, and IMPD submissions and Module 3/CTD documentation. You will work closely with Quality, Process Development, Manufacturing, Analytical Development, and Clinical teams to ensure regulatory strategies align with scientific and compliance requirements. The role also provides an opportunity to influence global regulatory strategy across the FDA, EMA, ANVISA, and other international jurisdictions. As an independent contributor, you will bring strong scientific writing, judgment, and organizational skills to a fast-paced biotechnology environment. The position is remote within the United States, with San Diego preferred for candidates who are able to work locally. \n Accountabilities: - Serve as a primary author and lead reviewer for CMC sections of late-stage and commercial regulatory submissions, including BLAs, MAAs, IMPDs, INDs, amendments, supplements, and related filings. - Author and review scientifically rigorous Module 3/CTD content covering drug substance, drug product, analytical development, manufacturing, and related CMC areas. - Support commercial lifecycle management activities, including post-approval submissions, CMC supplements, comparability protocols, manufacturing changes, labeling updates, and annual product reports. - Contribute to international regulatory submissions, particularly EMA and ANVISA filings, ensuring content meets jurisdiction-specific requirements. - Prepare and coordinate health authority interactions, including FDA Type A/B/C meetings, EMA Scientific Advice requests, and formal interactions with other global agencies.

- Develop meeting briefing documents, presentations, written responses, and other materials required for regulatory discussions and agency questions. - Partner with Process Development, Analytical Development, Manufacturing, Quality, and Clinical teams to provide CMC regulatory guidance on late-stage development activities and study design. - Support regulatory strategies related to process characterization and validation, comparability, analytical method validation, stability programs, scale-up, and technology transfer. - Prepare clear and comprehensive responses to health authority questions, deficiency letters, and requests for additional information across U. S. and international jurisdictions. - Monitor evolving global CMC regulations and cell and gene therapy guidance, contributing to regulatory intelligence and internal best-practice initiatives. - Track regulatory commitments, submission timelines, annual reporting requirements, and post-approval obligations to ensure timely and compliant execution. - Provide informal mentorship to junior regulatory professionals and contribute to the development of regulatory capabilities as the organization grows. Requirements - Bachelor’s degree in life sciences, chemistry, biochemistry, or a related discipline is required; an MS, PhD, PharmD, or equivalent advanced degree is preferred. - At least 7 years of regulatory CMC experience within the biopharmaceutical industry, including 3–5 years of direct, hands-on experience in cell therapy. - Experience with allogeneic and/or autologous cell therapy platforms is required; experience across both is an advantage. - Demonstrated late-stage and/or commercial CMC regulatory experience, with strong BLA and/or MAA submission experience highly preferred.